G1 Therapeutics to Participate in Two August Investor Conferences
RESEARCH TRIANGLE PARK, N.C., July 31, 2023 -- G1 Therapeutics, Inc. , a commercial-stage oncology company, today announced that it will participate in two August investor conferences. On Monday...